Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.377NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.5.3 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BB.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.86 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.7 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.12 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.7.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.1.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.390NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
N.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.319NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BG.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JF.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.572NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.397NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.3 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.523NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.116 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.38 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.595.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.340NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.437NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.452NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.400NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.25NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.2.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.16 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.46.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.37 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.336NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.317NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.397NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CM.6.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.54NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DR.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.26NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CM.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.5.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.59NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CA.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CP.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.3.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
ED.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CM.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used